Zealand Pharma A/S ADR (ZEAL)

NASDAQ
17.59
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    17.47 - 18.07
  • 52 wk Range:
    9.93 - 32.94

ZEAL Overview

Prev. Close
17.59
Day's Range
17.47-18.07
Revenue
277.51M
Open
18.03
52 wk Range
9.93-32.94
EPS
-25.77
Volume
0
Market Cap
1.22B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,080
P/E Ratio
-7.02
Beta
1.06
1-Year Change
-17.22%
Shares Outstanding
51,255,952
Next Earnings Date
-
What is your sentiment on Zealand Pharma ADR?
or
Market is currently closed. Voting is open during market hours.

Zealand Pharma A/S ADR News

Zealand Pharma A/S ADR Analysis

Zealand Pharma A/S ADR Company Profile

Zealand Pharma A/S ADR Company Profile

Employees
237

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin and Lyxumia; Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia, congenital hyperinsulinism, and post bariatric surgery hypoglycemia; and Dasiglucagon dual-hormone artificial pancreas for automated diabetes management. The company’s pipeline includes Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion Pharmaceuticals, Inc.; and Beta Bionics, Inc. The company was incorporated in 1998 and is headquartered in Copenhagen, Denmark.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell
  • It looks good , it 's very interesting , there is a smell of compression of short positions .I feel it will pay us soon , I entered the position at $ 19.28 . It would be a sin not to add this ATM . It seems to me that he will quickly double or even more if he needs a good volume
    0
    • This company seems to have quite some potential. Figures look very well and phase 3 results for one of their medicines are to be expected next quarter.See attached picture for the trendline of Zealand Pharma since the beginning of this year. The lines indicate the supports and resistances.See picture: https://invst.ly/b3946
      0